Maybe, let's hope so. For now we're losing momentum. Needs some news flow, of which there could be a number of possibilities, many of which were flagged in 4C.
Perhaps we're paying the price for the pivot in the platform and taking longer to get things established. There seems to be a lot of trials taking place. I think the RCH has been a tier 1 exposure site 3 times since the RNO Junior trial began, which may have impacted.
RNO Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held